Health Canada has approved Pfizer-BioNTech’s updated COVID-19 Comirnaty vaccine that targets Omicron’s BA.4 and BA.5 subvariants and is approved for use as a booster dose for people under 12 years and over.
• Read also: The consequences of the pandemic among young people studied
“Health Canada has licensed this vaccine following a thorough and independent scientific review of the evidence, which has demonstrated the safety and efficacy of this vaccine,” it said in a press release on Friday.
According to the ministry, this new version of Pfizer-BioNTech’s vaccine is expected to have a safety profile similar to that of the original COVID-19 vaccine.
Remember that Moderna’s bivalent vaccine has been available in Quebec since last month for protection against these same two variants.